11 – 20 of 76
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures
(
- Contribution to journal › Article
-
Mark
Characterization and Visualization of Vesicles in the Endo-Lysosomal Pathway with Surface-Enhanced Raman Spectroscopy and Chemometrics
(
- Contribution to journal › Article
-
Mark
Hippocampal dysfunction defines disease onset in Huntington's disease
(
- Contribution to journal › Article
-
Mark
Advancing pharmacotherapy for treating Huntington's disease : a review of the existing literature
(
- Contribution to journal › Article
-
Mark
A simple assessment model to quantifying the dynamic hippocampal neurogenic process in the adult mammalian brain
(
- Contribution to journal › Article
-
Mark
Gray and white matter imaging : A biomarker for cognitive impairment in early Parkinson's disease?
(
- Contribution to journal › Article
-
Mark
GSK-3β-induced Tau pathology drives hippocampal neuronal cell death in Huntington's disease : involvement of astrocyte-neuron interactions
(
- Contribution to journal › Article
-
Mark
Atomoxetine restores the response inhibition network in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Learning to be inflexible : Enhanced attentional biases in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Cognitive decline and quality of life in incident Parkinson's disease : The role of attention
(
- Contribution to journal › Article